HomeAI · summaries
Storia in 2 fonti
Mankind Pharma inks in-licensing pact with China's Chongqing Chenan Biopharmaceutical
Mankind Pharma has secured an exclusive agreement with Chongqing Chenan Biopharmaceutical. This partnership focuses on commercialising two insulin analogues for diabetes care. The deal will enhance Mankind Pharma's injectable diabetes segment offerings. These new products will strengthen the company's comprehensive patient portfolio.
Confronto fonti
2 prospettive sulla stessa storiaTimeline cronologica
- ·
thehindubusinessline.com
Mankind Pharma inks in-licensing pact with China’s Chongqing Chenan Biopharmaceutical on two insulin analogues
Mankind Pharma partners with Chongqing Chenan Biopharmaceutical to enhance diabetes care with two new insulin analogues in India.
- ·
economictimes.indiatimes.com
Mankind Pharma inks in-licensing pact with China's Chongqing Chenan Biopharmaceutical
Mankind Pharma has secured an exclusive agreement with Chongqing Chenan Biopharmaceutical. This partnership focuses on commercialising two insulin analogues for diabetes care. …